obesity; medications; semaglutide; tirzepatide

  1. Nelson Vergel

    Empower Pharmacy CEO Shaun Noorian Challenges Big Pharma Over GLP-1 Drug Access and Pricing

    Everyone is talking about GLP-1s. As these so-called "miracle drugs" for weight loss exploded in popularity, shortages quickly followed. That’s when compounding pharmacies stepped in, offering lower-cost, customizable versions of these medications. But are patients really getting the same...
  2. M

    Lean mass loss on GLP-1 receptor agonists: a downside of the “miracle drugs”

    Has anyone done a DEXA scan before and during use of any GLP-1 agonists (semaglutide, tizepatide) to assess body composition? In Peter Attia's recent blog, he eludes to the fact the GLP-1 agonists can cause loss of lean mass (in addition to fat loss), of particular concern in non-obese persons...
  3. madman

    Anti-Obesity Medications and Investigational Agents

    Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 Harold E. Bays, Angela Fitch, Sandra Christensen, Karli Burridge, Justin Tondt ABSTRACT Background: This “Anti-Obesity Medications and Investigational Agents: An...
Back
Top